Black Hawk Acquisition Corporation Announces Closing of $69,000,000 Initial Public Offering

Mar 24

Written By Jonathan Ginsberg

Jonathan Ginsberg

Vesicor Therapeutics, Inc. and Black Hawk Acquisition Corporation Enter into a Business Combination Agreement to Create a Biotechnology Company Advancing p53-based Cancer Therapeutics Delivered

Black Hawk Acquisition Corporation Announces Pricing of $69,000,000 Upsized Initial Public Offering